TerrAscend (TSNDF) Goodwill (2020 - 2026)

TerrAscend (TSNDF) posted quarterly Goodwill of $1.0 million for Q1 2026, down 99.08% quarter-over-quarter from $109.8 million in Q4 2025.

TerrAscend (TSNDF) Goodwill (2020 - 2026) Analysis & Trends

TerrAscend (TSNDF) has reported Goodwill for 7 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.

In Q1 2026, Goodwill changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (changed N/A YoY), while the FY2025 annual figure was $109.8 million, up 2.66% from the prior year.
Goodwill eased to $1.0 million in Q1 2026 per TSNDF's latest filing, from $109.8 million in the prior quarter.
Across five years, Goodwill topped out at $235.7 million in Q1 2022 and bottomed at $1.0 million in Q1 2026.
Historically, Goodwill has averaged $86.5 million across 5 years, with a median of $100.7 million in 2023.
Annual changes were most pronounced in 2023 — Goodwill grew 18.38% — and 2025, when it tumbled 97.34%.
TerrAscend's Goodwill stood at $90.3 million in 2022, then climbed by 18.38% to $106.9 million in 2023, then changed by 0.0% to $106.9 million in 2024, then gained by 2.66% to $109.8 million in 2025, then sank by 99.08% to $1.0 million in 2026.
Business Quant data shows TSNDF's Goodwill at $1.0 million in Q1 2026, $109.8 million in Q4 2025, and $2.8 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	TerrAscend	182.53 Mn	140.41 Mn	36.25 Mn

Download Data